Skip to content

iBio, Inc.

IBIO

CIK 0001420720

← back to feed
Revenue (TTM)
$300K
+77.8% YoY Q3 May 2026
Net Income (TTM)
−$27.3M
+26.2% YoY Q3 May 2026
EPS Diluted (TTM)
−$0.75
+73.1% YoY Q3 May 2026
Gross Margin
797.7%
Q3 May 2026
Operating Margin
-9,546.7%
Q3 May 2026
Net Margin
-9,101.3%
Q3 May 2026
Free Cash Flow (TTM)
−$32.31M
Q3 May 2026
Cash
$47.63M
Q3 May 2026
Total Debt
—
Q3 May 2026
Shares Outstanding
49.68M sh
Q3 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings